Banner

January 8, 2009

Scary Slides, Numbers From Getz

Site Profit Two Percent, Says Tufts

Clinical sites have it rough, and numbers from the Tufts Center for Drug Development show few heartening trends.

thumbnail
Scary Slides, Numbers From Getz

Site Profit Two Percent, Says Tufts

August 08, 2007

By SuzR

No wonder it’s hard for pharma and biotech companies to find and retain good clinical sites. Basic arithmetic and common courtesy are still sinking in. According to numbers from the Tufts Center for the Study of Drug Development (CSDD), on…

No articles available